Clinical Trial Update: Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adalimumab in Korean rheumatoid arthritis patients treated with methotrexate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED